Research graph
References from The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil. Local targets link to admitted publications; unresolved targets remain external evidence.
Progress in evidence-based medicine: a quarter century on
10.1016/s0140-6736(16)31592-6 · 2017 · External reference
Evidence-based medicine in times of crisis
10.1016/j.jclinepi.2020.07.002 · 2020 · External reference
The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19 – First, Do No Harm
10.1001/jamainternmed.2020.1853 · 2020 · External reference
Misguided Use of Hydroxychloroquine for COVID-19
10.1001/jama.2020.22389 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
2021 · External reference
COVID-19: The therapeutic landscape
10.1016/j.medj.2021.04.015 · 2021 · External reference
Guidelines should not pool evidence from uncomplicated and severe COVID-19
10.1016/s0140-6736(21)00469-4 · 2021 · External reference
Ivermectin for preventing and treating COVID-19
2021 · External reference
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials
2021 · External reference
Unresolved reference
External reference
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
2021 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
